Copyright
©The Author(s) 2023.
World J Orthop. Apr 18, 2023; 14(4): 218-230
Published online Apr 18, 2023. doi: 10.5312/wjo.v14.i4.218
Published online Apr 18, 2023. doi: 10.5312/wjo.v14.i4.218
Operative variable | Value |
Procedure type | |
Primary | 29 (52.7) |
Revision | 26 (47.3) |
Surgical indications | |
Osteogenic sarcoma | 22 (40.0) |
Giant cell tumor | 9 (16.4) |
Metastatic carcinoma | 8 (14.6) |
Soft-tissue sarcomaa | 4 (7.3) |
Chondrosarcoma | |
High-grade | 3 (5.5) |
Low-grade | 2 (3.6) |
Synovial chondromatosis | 2 (3.6) |
Multiple myeloma | 2 (3.6) |
Non-Hodgkin's lymphoma | 1 (1.8) |
Pigmented villonodular synovitis | 1 (1.8) |
Neoplasm of unspecified behavior | 1 (1.8) |
Primary mode of failure, henderson classification | |
Type 1 (soft-tissue failure) | 6 (10.9) |
Type 2 (aseptic loosening) | 5 (9.1) |
Type 3 (structural failure)b | 2 (3.6) |
Type 4 (periprosthetic infection) | 6 (10.9) |
Type 5 (tumor progression) | 1 (1.8) |
Number of previous surgeries (mean ± SD) | 1.1 ± 1.3 surgeries |
- Citation: Christ AB, Chung BC, Urness M, Mayer LW, Gettleman BS, Heckmann ND, Menendez LR. Clinical outcomes of cemented distal femur replacements with all-polyethylene tibial components for oncologic indications. World J Orthop 2023; 14(4): 218-230
- URL: https://www.wjgnet.com/2218-5836/full/v14/i4/218.htm
- DOI: https://dx.doi.org/10.5312/wjo.v14.i4.218